MedTrace Logo

Prospective Single Arm CAS - ROADSAVER Study

NCT03504228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1967

Last updated 2023-03-21

No results posted yet for this study

Summary

Approximately 2000 patients eligible for elective treatment with a Carotid Stent according to hospital routine practice in centers across Europe will be enrolled in the study. The maximum number of patients enrolled at each site will be not limited. Follow-ups are scheduled at discharge, 30 days, and 1 year, as per local practice. Each patient will have follow-up contacts via hospital visit and/or telephone.

Conditions

  • Carotid Artery Stenosis

Interventions

DEVICE

Roadsaver

Dual layer micromesh Roadsaver carotid stent

Sponsors & Collaborators

  • Terumo Europe N.V.

    lead INDUSTRY

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-23
Primary Completion
2021-02-18
Completion
2022-06-20

Countries

  • Belgium
  • Czechia
  • France
  • Germany
  • Hungary
  • Latvia
  • Netherlands
  • North Macedonia
  • Poland
  • Portugal
  • Serbia
  • Slovakia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03504228 on ClinicalTrials.gov